{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:26:24Z","timestamp":1782311184986,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jpba.2023.115936","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T19:45:22Z","timestamp":1703360722000},"page":"115936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Analysis on dynamic changes of etizolam and its metabolites and exploration of its development prospect using UPLC-Q-exactive-MS"],"prefix":"10.1016","volume":"240","author":[{"given":"Zhaowei","family":"Jie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fubang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duoqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2023.115936_bib1","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/PAF.0000000000000803","article-title":"Clonazolam intoxication case report: danger of designer benzodiazepines","volume":"43","author":"Moore","year":"2022","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.jpba.2023.115936_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/17512433.2023.2170349","article-title":"Designer benzodiazepines: an update","volume":"16","author":"Yu","year":"2023","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2023.115936_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jat\/bkad005","article-title":"Bromazolam blood concentrations in postmortem cases\u2014a British Columbia perspective","volume":"47","author":"M\u00e9rette","year":"2023","journal-title":"J. Anal. Toxicol."},{"issue":"4","key":"10.1016\/j.jpba.2023.115936_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/dar.13052","article-title":"Etizolam: a rapid review on pharmacology, non-medical use and harms","volume":"39","author":"Nielsen","year":"2020","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.jpba.2023.115936_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/bcpt.13786","article-title":"Retrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis","volume":"131","author":"Axelsson","year":"2022","journal-title":"Basic Clin. Pharma Tox"},{"key":"10.1016\/j.jpba.2023.115936_bib6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/eurpub\/ckac161","article-title":"Evidence of the emergence of illicit benzodiazepines from online drug forums","volume":"32","author":"Sarker","year":"2022","journal-title":"Eur. J. Public Health"},{"issue":"1","key":"10.1016\/j.jpba.2023.115936_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jat\/bkac017","article-title":"The evolution toward designer benzodiazepines in drug-facilitated sexual assault cases","volume":"47","author":"P\u00e9rez Orts","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2023.115936_bib8","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00414-017-1541-6","article-title":"Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer","volume":"131","author":"El Balkhi","year":"2017","journal-title":"Int J. Leg. Med"},{"key":"10.1016\/j.jpba.2023.115936_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/dta.2967","article-title":"Metabolism and excretion of the benzodiazepine analogue etizolam in the horse","volume":"13","author":"Johnson","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2023.115936_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/jat\/bkac096","article-title":"Etizolam and its major metabolites: a short Review","volume":"47","author":"Al Bahri","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jpba.2023.115936_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00280074","article-title":"Single and multiple dose pharmacokinetics of etizolam in healthy subjects","volume":"40","author":"Fracasso","year":"1991","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2023.115936_bib12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00228-005-0032-8","article-title":"Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity]","volume":"61","author":"Fukasawa","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.jpba.2023.115936_bib13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1248\/bpb.28.280","article-title":"Pharmacokinetic interactions between Japanese traditional Kampo medicine and modern medicine (IV). Effect of Kamisyoyosan and Tokisyakuyakusan on the pharmacokinetics of etizolam in rats","volume":"28","author":"Makino","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpba.2023.115936_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01079","article-title":"Inhibitory effect of imperatorin on the pharmacokinetics of diazepam in vitro and in vivo","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.jpba.2023.115936_bib15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/17425255.2018.1483338","article-title":"Influence of ethanol on the metabolism of alprazolam","volume":"14","author":"Huang","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpba.2023.115936_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s002130000469","article-title":"A comparison of plasma alprazolam concentrations following different routes of chronic administration in the Sprague-Dawley rat: implications for psychotropic drug research","volume":"151","author":"Skelton","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpba.2023.115936_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106437","article-title":"Safety, pharmacokinetics and exploratory exposure-response analysis of CX3002, a novel inhibitor of Xa, in Chinese healthy subjects","volume":"185","author":"Chen","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"issue":"13","key":"10.1016\/j.jpba.2023.115936_bib18","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1080\/17415977.2021.1982934","article-title":"RBF level-set based fully-nonlinear fluorescence photoacoustic pharmacokinetic tomography","volume":"29","author":"Gottam","year":"2021","journal-title":"Inverse Probl. Sci. Eng."},{"issue":"4","key":"10.1016\/j.jpba.2023.115936_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/dmd.120.000023","article-title":"Revisiting nonlinear Bosentan pharmacokinetics by physiologically based pharmacokinetic modeling: target binding, albeit not a major contributor to nonlinearity, can offer prediction of target occupancy","volume":"49","author":"Koyama","year":"2021","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"10.1016\/j.jpba.2023.115936_bib20","doi-asserted-by":"crossref","DOI":"10.1007\/s11081-020-09571-2","article-title":"Cluster Gauss\u2013Newton method: an algorithm for finding multiple approximate minimisers of nonlinear least squares problems with applications to parameter estimation of pharmacokinetic models","volume":"31","author":"Aoki","year":"2020","journal-title":"Optim. Eng."},{"issue":"6","key":"10.1016\/j.jpba.2023.115936_bib21","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/cts.13272","article-title":"Physiologically\u2010based pharmacokinetic model\u2010based translation of OATP1B\u2010mediated drug\u2013drug interactions from coproporphyrin I to probe drugs","volume":"15","author":"Mochizuki","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jpba.2023.115936_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jare.2020.05.001","article-title":"Half-life determination of inorganic-organic hybrid nanomaterials in mice using laser-induced breakdown spectroscopy","volume":"24","author":"Chu","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jpba.2023.115936_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00280074","article-title":"Single and multiple dose pharmacokinetics of etizolam in healthy subjects","volume":"40","author":"Fracasso","year":"1991","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.jpba.2023.115936_bib24","unstructured":"Home Office, 2017. Impact Assessment: Control of etizolam, related drugs and U-47,700. London. https:\/\/www.legislation.gov.uk\/ukia\/2017\/71\/pdfs\/ukia_20170071_en.pdf ."},{"key":"10.1016\/j.jpba.2023.115936_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116459","article-title":"Designer benzodiazepine rat pharmacokinetics: a comparison of alprazolam, flualprazolam and flubromazolam[J]","volume":"465","author":"Canfield","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"13","key":"10.1016\/j.jpba.2023.115936_bib26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4155\/bio-2017-0067","article-title":"LC\u2013MS determination of triazolam and its hydroxy metabolites in mouse dried blood spots: application to transgenic mouse pharmacokinetic studies","volume":"9","author":"Kole","year":"2017","journal-title":"Bioanalysis"},{"issue":"6","key":"10.1016\/j.jpba.2023.115936_bib27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acsmedchemlett.8b00018","article-title":"Strategy for extending half-life in drug design and its significance","volume":"9","author":"Gunaydin","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"issue":"1-3","key":"10.1016\/j.jpba.2023.115936_bib28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2008.08.012","article-title":"Case report: etizolam and its major metabolites in two unnatural death cases","volume":"182","author":"Nakamae","year":"2008","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2023.115936_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2022.111324","article-title":"Toxicity of designer benzodiazepines: a case of etizolam and cocaine intoxication","volume":"336","author":"Drevin","year":"2022","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2023.115936_bib30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00228-005-0904-y","article-title":"Induction of the metabolism of etizolam by carbamazepine in humans","volume":"61","author":"Kondo","year":"2005","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.jpba.2023.115936_bib31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/metabo13060699","article-title":"Metabolic profile analysis of designer benzodiazepine etizolam in zebrafish and human liver microsomes","volume":"13","author":"Jie","year":"2023","journal-title":"Metabolites"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523007057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708523007057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:36:11Z","timestamp":1760002571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708523007057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":31,"alternative-id":["S0731708523007057"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115936","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis on dynamic changes of etizolam and its metabolites and exploration of its development prospect using UPLC-Q-exactive-MS","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2023.115936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115936"}}